Highly Controllable and Green Reduction of Graphene Oxide to Flexible Graphene Film with High Strength

- a Carbon Research Laboratory, Liaoning Key Lab for Energy Materials and Chemical Engineering, State Key Lab of Fine Chemicals, Dalian University of Technology, Dalian 116024, China
- b Department of Materials Science and Engineering, and A.J. Drexel Nanotechnology Institute, Drexel University, Philadelphia, Pennsylvania 19104, USA

Highlights
- •Graphene was synthesized by an effective and environmentally friendly approach.
- •We introduced a facile X-ray diffraction analysis method to investigate the reduction process from graphene oxide to graphene.
- •Flexible graphene films were prepared by self-assembly of the graphene sheets.
- •The strength of the graphene films depends on the reduction degree of graphene.
Graphene film with high strength was fabricated by the assembly of graphene sheets derived from graphene oxide (GO) in an effective
and environmentally friendly approach.
Highly controllable reduction of GO to chemical converted graphene (CCG) was achieved with sodium citrate as a facile reductant, in which the reduction process was monitored by XRD analysis and UV-vis absorption spectra. Self-assembly of the as-made CCG sheets results in a flexible CCG film.
This method may open an avenue to the easy and scalable preparation of graphene film with high strength which has promising potentials in many fields where strong, flexible and electrically conductive films are highly demanded.
- Highly controllable and green reduction of GO to chemical converted graphene (CCG) was achieved with sodium citrate as a facile reductant. Self-assembly of the as-made CCG sheets results in a flexible CCG film, of which the tensile strength strongly depends on the deoxygenation degree of graphene sheets.
|
|
|
|---|---|
|
Fig. 4. (a) Stepwise reduction of GO to form CCG. (b) UV-vis absorption spectra of GO dispersed in water with different concentrations. The inset demonstrates the linear relationship between the maximum absorbance at the wavelength of 231 nm and the concentration of GO. (c) UV-vis spectra of GO dispersion change as a function of reaction time (from 0 to 18 h), the maximum absorbance of GO at 231 nm gradually red shifts to 268 nm.
|
Fig. 5. Photograph of the apparatus for measurement of I-V curves (a), and the I-V curves of the products obtained from different reaction times (b). |
|
|
|
| Fig. 6. (a) Digital photograph of a free-standing self-assembled graphene film, inset picture shows a strip of the film. (b) TEM image of CCG. (c) Cross sectional views of a self-assembled film, inset SEM image shows the side view of a CCG film at a higher magnification. (d) Optical transmittance of GO and CCG films. Inset shows photographs of GO (left) and CCG (right) films. | Fig. 7. (a) Tensile strength of CCG films prepared at different reaction times. (b) Digital photograph of a strip of graphene film supporting 275 g of load (the weight and the clamp), which is equal to 48 MPa of stress. |
Source: www.sciencedirect.com
RELATED ITEMS:
Increasing Energy Storage in Electrochemical Capacitors with Ionic Liquid Electrolytes and Nanostructured Carbon Electrodes





MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
